EUVIMEDEUVIMED entdecken
Open Access

PET-based immunomapping of intratumoral CD4 + cells to monitor acquired resistance to checkpoint inhibitors

Stefania Pezzana iD, Simone Blaess, Bjoern Traenkle iD, Anna Schaefer, Lara Ruoff, Bredi Tako, Salvador Castaneda Vega iD, Philipp D Kaiser iD, Teresa Wagner iD, Irene Gonzalez-Menendez, Leticia Quintanilla-Martinez, Alexander Rochwarger iD und 16 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.adw1924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Stefania Pezzana und 27 weiteren Autor:innen. Beteiligte Einrichtung: Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University Hospital Tuebingen, University of Tuebingen, Tuebingen…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, CD4-Positive T-Lymphocytes, Immune Checkpoint Inhibitors, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD4 + T cells are crucial in shaping response and resistance to immunotherapy. To enhance our understanding of their multifaceted functions, we developed copper-64–radiolabeled nanobodies targeting the human CD4 receptor ( 64 Cu-CD4-Nb1) for positron emission tomography (PET). In human CD4-receptor knock-in mice, 64 Cu-CD4-Nb1 specifically accumulated in different orthotopic tumors, correlating with histological CD4 + cell densities. Based on intratumoral CD4 + cell distribution patterns within the core and periphery, we distinguished responders to combined αPD-1/4-1BB antibodies early on-treatment. CD4-PET identified resistance to αPD-1 monotherapy, which was mitigated by adding regulatory T cell–depleting α4-1BB antibodies. Patients with early-stage non–small cell lung cancer who relapsed after neoadjuvant αPD-L1 therapy revealed low CD4 + T cell densities in the tumor core. In human and mouse tumor tissues, regulatory T cells correlated with CD4 + cell densities. Thus, visualizing the spatial distribution patterns of CD4 + cells by PET offers mechanistic insights into CD4-mediated therapy efficacy, with great potential for guiding combinatorial immunotherapies in patients with cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyCD4-Positive T-LymphocytesImmune Checkpoint InhibitorsDrug Resistance, NeoplasmCarcinoma, Non-Small-Cell LungAnimalsHumansMiceT-Lymphocytes, RegulatoryCopper RadioisotopesCell Line, TumorLung NeoplasmsSingle-Domain AntibodiesImmunotherapy

Substanzen

Immune Checkpoint InhibitorsCopper RadioisotopesSingle-Domain AntibodiesCopper-64

Autor:innen und Institutionen

  • Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University Hospital Tuebingen, University of Tuebingen, Tuebingen, Germany.
  • NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.
  • Department of Nuclear Medicine, University Hospital Tuebingen, University of Tuebingen, Tuebingen, Germany.
  • Pharmaceutical Biotechnology, University of Tuebingen, Tuebingen, Germany.
  • Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tuebingen, Tuebingen, Germany.
  • Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tuebingen, University of Tuebingen, Tuebingen, Germany.

ORCID-Profile: Stefania Pezzana, Bjoern Traenkle, Salvador Castaneda Vega, Philipp D Kaiser, Teresa Wagner, Alexander Rochwarger, Christian M Schürch, Simon Riel, Martin Schaller, Evelien A J van Genugten, Iris A E van der Hoorn, Mark A J Gorris, I Jolanda M de Vries, Michel M van den Heuvel, Erik H J G Aarntzen, Andreas Maurer, Ulrich Rothbauer, Bernd J Pichler, Dominik Sonanini

Zitieren

APA

Pezzana, S., Blaess, S., Traenkle, B., Schaefer, A., Ruoff, L., Tako, B., Castaneda Vega, S., Kaiser, P. D., Wagner, T., Gonzalez-Menendez, I., Quintanilla-Martinez, L., Rochwarger, A., Schürch, C. M., Riel, S., Schaller, M., van Genugten, E. A. J., van der Hoorn, I. A. E., Gorris, M. A. J., Steinvoort, M., …, & Sonanini, D. (2025). PET-based immunomapping of intratumoral CD4 + cells to monitor acquired resistance to checkpoint inhibitors. Science Advances. https://doi.org/10.1126/sciadv.adw1924

Vancouver

Pezzana S, Blaess S, Traenkle B, Schaefer A, Ruoff L, Tako B, et al. PET-based immunomapping of intratumoral CD4 + cells to monitor acquired resistance to checkpoint inhibitors. Science Advances. 2025. doi:10.1126/sciadv.adw1924

BibTeX
@article{Pezzana2025,
  author = {Pezzana, Stefania and Blaess, Simone and Traenkle, Bjoern and Schaefer, Anna and Ruoff, Lara and Tako, Bredi and Castaneda Vega, Salvador and Kaiser, Philipp D and Wagner, Teresa and Gonzalez-Menendez, Irene and Quintanilla-Martinez, Leticia and Rochwarger, Alexander and Schürch, Christian M and Riel, Simon and Schaller, Martin and van Genugten, Evelien A J and van der Hoorn, Iris A E and Gorris, Mark A J and Steinvoort, Megan and Peeters, Eva and de Vries, I Jolanda M and van den Heuvel, Michel M and Aarntzen, Erik H J G and Maurer, Andreas and Rothbauer, Ulrich and Pichler, Bernd J and Kneilling, Manfred and Sonanini, Dominik},
  title = {PET-based immunomapping of intratumoral CD4 + cells to monitor acquired resistance to checkpoint inhibitors},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adw1924}
}
Kostenlos starten →